Efficacy and safety of an inactivated vaccine against Salmonid alphavirus (family Togaviridae).
Pancreas disease (PD) in salmonid fish is caused by an infection with Salmonid alphavirus (SAV) and remains as one of the major health problems in the European fish farming industry. Sequence studies have revealed a genetic diversity among viral strains. A subtype of SAV (SAV3) is causing an epizootic in farmed salmonids in Norway. Here we evaluate efficacy and safety of an inactivated virus vaccine based on ALV405, a strain of SAV3 that was isolated from Norwegian salmon. The vaccine provided an average relative percent survival (RPS) of 98.5 in an intraperitoneal challenge model, and induced nearly total protection against PD in a cohabitant challenge model. It provided significant protection against SAV-induced mortality also in a field trial under industrial conditions. Local reactions seen as melanization and adhesions in the visceral cavity were less severe than those induced by two commercial vaccines. Finally, we demonstrated that the protection is not impaired when the ALV405 antigen is combined with other viral or bacterial antigens in a polyvalent vaccine. The results confirm that efficient and safe protection against SAV infection and development of PD is possible using an inactivated virus vaccine, both alone and as a component in a polyvalent vaccine.
PHARMAQ AS, Skøyen, N-0275 Oslo, Norway. marius.karlsen@pharmaq.no
Marius
M
Karlsen
Terje
T
Tingbø
Inge-Tom
IT
Solbakk
Øystein
Ø
Evensen
Anette
A
Furevik
Anne
A
Aas-Eng
D000818:Animals; D005393:Fish Diseases / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D009664:Norway / Q000453:epidemiology; D020317:Salmo salar; D016019:Survival Analysis; D014035:Togaviridae / Q000276:immunology* / Q000302:isolation & purification / Q000472:pathogenicity; D014036:Togaviridae Infections / Q000453:epidemiology / Q000517:prevention & control / Q000662:veterinary* / Q000821:virology; D015164:Vaccines, Inactivated / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology; D014765:Viral Vaccines / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology*
D015164:Vaccines, Inactivated; D014765:Viral Vaccines